Company intelligence / Profile preview

Sierra Neurovision

Toulouse, Francesierra-neurovision.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Sierra Neurovision has developed EyA™, a unique, precise, rapid, and easy-to-use eye-tracking solution that enables detailed measurement of binocular vision. Their mission is to democratize access to advanced visual diagnostics—especially for children with learning disabilities—and optimize visual performance using actionable data derived from oculometric analysis. The company collaborates with leading French research institutions to validate its methods.

Therapeutic areas: OphthalmologyNeurology
Modalities: DeviceDigital health toolEye tracking technology
Industry: Physiological Monitoring

Partnerships

CNRSLaboratoire ICAREcole Normale Supérieure de LyonISVBPI FranceNetwork of healthcare professionals

Beyond the preview

Go deeper on Sierra Neurovision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sierra Neurovision.

Explore the full profile